Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme

Xiaodong Zhu(Guangxi Medical University), Mu Yang(Nanjing University of Chinese Medicine), Bangrong Cao(University of Electronic Science and Technology of China), Jiao-Ming Li(University of Electronic Science and Technology of China), Shun Lü(Shanghai Jiao Tong University), Jinsong Liu(Guangzhou Institutes of Biomedicine and Health), Mei Feng(Third People's Hospital of Chengdu), Jinyi Lang(University of Electronic Science and Technology of China)
Translational Cancer Research
October 1, 2020
10.21037/tcr-20-2906
Cited by 13

Related Papers

A Draft Sequence of the Rice Genome ( <i>Oryza sativa</i> L. ssp. <i>indica</i> )
|Science|2002|4.3k
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k